United Services Automobile Association Grows Position in Chemed Co. (NYSE:CHE)

Share on StockTwits

United Services Automobile Association raised its holdings in shares of Chemed Co. (NYSE:CHE) by 1.2% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 5,991 shares of the company’s stock after acquiring an additional 71 shares during the quarter. United Services Automobile Association’s holdings in Chemed were worth $2,162,000 as of its most recent SEC filing.

A number of other large investors have also bought and sold shares of the business. BlackRock Inc. raised its holdings in Chemed by 2.5% during the second quarter. BlackRock Inc. now owns 1,697,275 shares of the company’s stock valued at $612,445,000 after acquiring an additional 42,102 shares during the period. FMR LLC increased its holdings in shares of Chemed by 27.0% in the first quarter. FMR LLC now owns 311,951 shares of the company’s stock worth $99,847,000 after purchasing an additional 66,276 shares during the last quarter. Investec Asset Management LTD increased its holdings in shares of Chemed by 7.3% in the second quarter. Investec Asset Management LTD now owns 269,948 shares of the company’s stock worth $97,408,000 after purchasing an additional 18,449 shares during the last quarter. Invesco Ltd. increased its holdings in shares of Chemed by 7.4% in the second quarter. Invesco Ltd. now owns 262,075 shares of the company’s stock worth $94,567,000 after purchasing an additional 18,100 shares during the last quarter. Finally, TimesSquare Capital Management LLC increased its holdings in shares of Chemed by 27.9% in the second quarter. TimesSquare Capital Management LLC now owns 217,000 shares of the company’s stock worth $78,302,000 after purchasing an additional 47,300 shares during the last quarter. 87.12% of the stock is currently owned by institutional investors and hedge funds.

In other Chemed news, Director George J. Walsh III bought 500 shares of the company’s stock in a transaction on Wednesday, August 7th. The stock was acquired at an average price of $412.86 per share, for a total transaction of $206,430.00. Following the completion of the transaction, the director now directly owns 4,520 shares of the company’s stock, valued at $1,866,127.20. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, Director Donald E. Saunders sold 400 shares of the business’s stock in a transaction that occurred on Monday, August 12th. The shares were sold at an average price of $432.87, for a total value of $173,148.00. Following the transaction, the director now owns 7,408 shares of the company’s stock, valued at approximately $3,206,700.96. The disclosure for this sale can be found here. Insiders have sold 46,812 shares of company stock worth $20,005,507 over the last three months. 3.96% of the stock is currently owned by insiders.

Several equities research analysts have recently issued reports on CHE shares. ValuEngine cut Chemed from a “buy” rating to a “hold” rating in a report on Wednesday, October 2nd. Bank of America lifted their target price on Chemed from $470.00 to $500.00 and gave the stock a “buy” rating in a report on Friday, September 6th. Oppenheimer lifted their target price on Chemed from $400.00 to $430.00 and gave the stock an “outperform” rating in a report on Thursday, August 1st. Finally, Royal Bank of Canada lifted their target price on Chemed to $405.00 and gave the stock a “sector perform” rating in a report on Monday, July 29th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and two have issued a buy rating to the company’s stock. The company has an average rating of “Hold” and an average price target of $411.25.

Shares of NYSE CHE opened at $403.62 on Wednesday. The business’s 50 day moving average is $423.93 and its two-hundred day moving average is $370.37. The company has a debt-to-equity ratio of 0.25, a current ratio of 0.81 and a quick ratio of 0.78. Chemed Co. has a 1-year low of $260.03 and a 1-year high of $441.79. The stock has a market capitalization of $6.62 billion, a P/E ratio of 33.83, a PEG ratio of 2.81 and a beta of 1.11.

Chemed (NYSE:CHE) last issued its quarterly earnings data on Thursday, July 25th. The company reported $3.36 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $3.09 by $0.27. Chemed had a return on equity of 35.63% and a net margin of 10.94%. The company had revenue of $473.60 million for the quarter, compared to analysts’ expectations of $471.72 million. During the same period in the previous year, the firm posted $2.81 earnings per share. The firm’s revenue for the quarter was up 7.2% on a year-over-year basis. As a group, equities research analysts anticipate that Chemed Co. will post 13.54 earnings per share for the current fiscal year.

About Chemed

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers in the United States. It operates through two segments, VITAS and Roto-Rooter. The company also offers plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers through company-owned and independent contractors, and franchised locations.

Further Reading: How to Invest in a Bull Market

Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Co. (NYSE:CHE).

Institutional Ownership by Quarter for Chemed (NYSE:CHE)

Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.